Hiperlipidemias primarias. Clasificación, diagnóstico y riesgo asociado

R Charles Scriver, The Metabolic and Molecular Bases of Inherited Disease ,(1995)

Scott M. Grundy, Cholesterol-lowering therapy : evaluation of clinical trial evidence M. Dekker. ,(2000)

J. L. Goldstein, MOLECULAR MEDICINE: The Cholesterol Quartet Science. ,vol. 292, pp. 1310- 1312 ,(2001) , 10.1126/SCIENCE.1061815

Philippa J. Talmud, Genetic determinants of plasma triglycerides: impact of rare and common mutations. Current Atherosclerosis Reports. ,vol. 3, pp. 191- 199 ,(2001) , 10.1007/S11883-001-0061-4

Hans H. Wittrup, Anne Tybjærg-Hansen, Børge G. Nordestgaard, Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease A Meta-Analysis Circulation. ,vol. 99, pp. 2901- 2907 ,(1999) , 10.1161/01.CIR.99.22.2901

Fernando Civeira, Miguel Pocoví, Ana Cenarro, Elena Casao, Elisabet Vilella, Jordi Joven, José González, Angel L. Garcia-Otín, JoséM. Ordovás, Apo E variants in patients with type III hyperlipoproteinemia Atherosclerosis. ,vol. 127, pp. 273- 282 ,(1996) , 10.1016/S0021-9150(96)05969-2

Gerd Assmann, Arnold von Eckardstein, Harald Funke, Lecithin: cholesterol acyltransferase deficiency and fish-eye disease Current Opinion in Lipidology. ,vol. 2, pp. 110- 117 ,(1991) , 10.1097/00041433-199104000-00009

Mi-Hye Lee, Kangmo Lu, Shailesh B. Patel, Genetic basis of sitosterolemia. Current Opinion in Lipidology. ,vol. 12, pp. 141- 149 ,(2001) , 10.1097/00041433-200104000-00007

Rodrigo Alonso, Sergio Castillo, Fernando Civeira, José Puzo, Juan José de la Cruz, Miguel Pocoví, Pedro Mata, Hipercolesterolemia familiar heterocigota en España. Estudio descriptivo de 819 casos no relacionados Medicina Clinica. ,vol. 118, pp. 487- 492 ,(2002) , 10.1016/S0025-7753(02)72428-7

Klaus A. Dugi, Karin Brandauer, Nikolaus Schmidt, Barbara Nau, Jochen G. Schneider, Stefani Mentz, Tanja Keiper, Juergen R. Schaefer, Christoph Meissner, Horst Kather, Malte L. Bahner, Walter Fiehn, Joerg Kreuzer, Low Hepatic Lipase Activity Is a Novel Risk Factor for Coronary Artery Disease Circulation. ,vol. 104, pp. 3057- 3062 ,(2001) , 10.1161/HC5001.100795